Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries IM Cannabis Corp (CSE: IMCC ) 3.100 -0.150 (-4.62%) Official Closing Price Updated: 10:37 AM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 991 Open 3.100 Bid (Size) 0.5900 (1,000) Ask (Size) 3.250 (100) Prev. Close 3.250 Today's Range 3.100 - 3.110 52wk Range 0.2400 - 3.750 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News IM Cannabis Announces Major Share Consolidation Plan: What Investors Need To Know July 05, 2024 IM Cannabis announces a share consolidation effective July 12, aiming to enhance marketability and streamline shares. Via Benzinga Topics Cannabis Exposures Cannabis Global Weed Business: Flora Buys Australian Vaporizers As IM Cannabis Doubles Down On Germany June 05, 2024 Lifeist Wellness Inc. (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF) said on Wednesday the sale of Australian Vaporizers Pty Ltd., its wholly owned Australian subsidiary to Flora Growth Corp. (NASDAQ:... Via Benzinga Topics Cannabis Exposures Cannabis Performance YTD +620.93% +620.93% 1 Month +392.06% +392.06% 3 Month +269.05% +269.05% 6 Month +1007.14% +1007.14% 1 Year +179.28% +179.28% More News Read More IM Cannabis Doubles Down On Germany Following Legalization Policy Change, Reports YoY Drop In Q1 Gross Profit And Revenue May 08, 2024 Via Benzinga Topics Cannabis Exposures Cannabis Avant Brands Bolsters International Growth in German Cannabis Market Through Partnership with IMC April 04, 2024 Via ACCESSWIRE IM Cannabis' Q4 Revenue: Gross Profit Drops Due To Negative Impact Of Israel-Hamas War, Sees Germany As Growth Opportunity March 28, 2024 Via Benzinga Topics Cannabis Exposures Cannabis IM Cannabis Stock Drops On Q2 Earnings, CEO Touts Strategic Decisions That Led To 'Sustainable Profitability' August 14, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Avant Brands and IM Cannabis Announce the Launch of BLK MKT in Israel October 12, 2022 Via ACCESSWIRE IM Cannabis announces Focus Medical's Import of 400 Kilograms of Premium-Indoor-Grown Dried Cannabis from Canada to Israel January 19, 2022 From IM Cannabis Corp. Via AccessWire Topics Cannabis Economy Exposures Cannabis Supply Chain IM Cannabis Corp. Appoints Rinat Efrima as New Chief Executive Officer of IMC Holdings, the Company’s Israeli Subsidiary January 13, 2022 From IM Cannabis Corp. Via AccessWire Topics Cannabis Exposures Cannabis IM Cannabis to Launch WAGNERS Brand in Germany December 07, 2021 From IM Cannabis Corp. Via AccessWire Topics Cannabis Exposures COVID-19 Cannabis IM Cannabis To Buy Jerusalem-Based Medical Marijuana Pharmacy For $4.9M In Cash And Stock December 01, 2021 Via Benzinga Topics Cannabis Exposures Cannabis IM Cannabis to Acquire Oranim, Jerusalem's Leading Medical Cannabis Pharmacy December 01, 2021 From IM Cannabis Corp. Via AccessWire Topics Cannabis Exposures Cannabis IM Cannabis To Debut WAGNERS Brand In Israel After Receiving Regulatory Approval November 30, 2021 Via Benzinga Topics Cannabis Exposures Cannabis IM Cannabis Announces Focus Medical's Receipt of Israeli Ministry of Health Import Permit; Plans to Launch WAGNERS Brand in Israel November 29, 2021 From IM Cannabis Corp. Via AccessWire Topics Cannabis Exposures COVID-19 Cannabis IM Cannabis Announces Fourth Installment of Shares in Connection with the Panaxia Transaction November 18, 2021 From IM Cannabis Corp. Via AccessWire Topics Cannabis Law Enforcement Exposures COVID-19 Cannabis Legal IM Cannabis Announces Third Quarter 2021 Financial Results and Provides Outlook and Business Update November 15, 2021 From IM Cannabis Corp. Via AccessWire Topics Cannabis Law Enforcement Exposures COVID-19 Cannabis Legal IMC Announces Third Installment of Shares in Connection with the Panaxia Transaction October 20, 2021 From IM Cannabis Corp. Via AccessWire Topics Cannabis Law Enforcement Exposures COVID-19 Cannabis Legal IMC Provides Further Details on Panaxia Transaction September 08, 2021 From IM Cannabis Corp. Via AccessWire Topics Cannabis Intellectual Property Law Enforcement Exposures COVID-19 Cannabis Intellectual Property IM Cannabis Announces Q2 2021 Financial Results and Signing of Definitive Agreement to Acquire Vironna Pharm, Accelerating its Vertical Integration Strategy in Israel August 16, 2021 From IM Cannabis Corp. Via AccessWire Topics Cannabis Intellectual Property Law Enforcement Exposures COVID-19 Cannabis Intellectual Property IMC Partners with Leading US Brand to Launch cbdMD Products in Israel and Provides Further Details on Panaxia Transaction August 09, 2021 From IM Cannabis Corp. Via AccessWire Topics Cannabis Law Enforcement Exposures COVID-19 Cannabis Legal IMC Announces Results of its Annual General and Special Meeting of Shareholders August 03, 2021 From IM Cannabis Corp. Via AccessWire Topics Cannabis Exposures Cannabis IMC Accelerates its Israeli Retail Position through Acquisition of Leading Retailer and Distributor Pharm Yarok and Rosen High Way July 28, 2021 From IM Cannabis Corp. Via AccessWire Topics Cannabis Intellectual Property Law Enforcement Exposures COVID-19 Cannabis Intellectual Property IM Cannabis Provides Update on German Operations and Financial Outlook July 23, 2021 From IM Cannabis Corp. Via AccessWire Topics Cannabis Law Enforcement Exposures COVID-19 Cannabis Legal IM Cannabis Provides Business, Legal and Regulatory Update July 13, 2021 From IM Cannabis Corp. Via AccessWire Topics Cannabis Law Enforcement Exposures COVID-19 Cannabis Legal IM Cannabis Closes Acquisition of MYM Nutraceuticals July 09, 2021 From IM Cannabis Corp. Via AccessWire Topics Cannabis Law Enforcement Exposures COVID-19 Cannabis Legal Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
